Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Other Operating Expenses (2016 - 2017)

Historic Other Operating Expenses for Bone Biologics (BBLG) over the last 2 years, with Q2 2017 value amounting to -$3.5 million.

  • Bone Biologics' Other Operating Expenses changed N/A to -$3.5 million in Q2 2017 from the same period last year, while for Dec 2017 it was -$3.5 million, marking a year-over-year decrease of 7248893.46%. This contributed to the annual value of -$2.7 million for FY2017, which is 5635308.52% down from last year.
  • According to the latest figures from Q2 2017, Bone Biologics' Other Operating Expenses is -$3.5 million.
  • Over the past 5 years, Bone Biologics' Other Operating Expenses peaked at -$4862.0 during Q1 2016, and registered a low of -$3.5 million during Q2 2017.